NIAID Funding News, September 21, 2022

September 21, 2022 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  Help Spread the Word of a New NIH Fellowship Program The NIH Medical Scientist Partnership Program will be a trans-NIH effort to support combined degree candidates by providing them an option to conduct doctoral research in an NIH Intramural laboratory. Opportunities and Resources Conduct Research to Improve Protective Immunity Following Immunization NIAID will support studies that define and characterize components and mechanisms of the immune system that lead to sustained immunity and identify common versus distinct durable immune mechanisms triggered by vaccines compared to natural infection. Contract Solicitation Focuses on Enhancing MTB Lab Testing in NIAID Clinical Trials The Mycobacterium tuberculosis (MTB) Quality Assessment Program will serve NIAID-sponsored and collaborating clinical trial networks and cohorts as well as individual grantees conducting research in and outside the United States. Research Resource Program Supports Laboratory of Developmental Biology The initiative aims to foster an understanding of underlying developmental biology of normal and abnormal human development as well as human pathologies through collecting, identifying, staging, and distributing conceptal tissues for use in studies. In The News Don't Let Dollars Expire Upon Payment Management System Drawdown Grantees, take note: You have 120 days after your grant's period of performance end date to liquidate obligations by drawing funds from the Payment Management System. New Research Sharing Policy to Speed Access to Results As directed by the White House, NIH will revise its public access policy to enable researchers, clinicians, students, and the public to access research results immediately upon publication. Pandemic Exception Ends for Semiannual Inspection of Animal Facilities Begining October 1, 2022, all Assured institutions, including those with expiring waivers, must conduct semiannual animal facility inspections as scheduled and required by Public Health Service policy. Advice Corner Data Management and Sharing Implementation for Contracts Contract solicitations likely to generate scientific data will include proposal instructions that direct offerors to submit a Data Management and Sharing Plan to the funding institute as part of the technical proposal. Reader Questions "Are there any steps I should take before submitting an investigator-initiated program project (P01) grant application?" "Is there a limit on how many times a research project (R01) grant can be renewed?" New Funding Opportunities PAR-22-241, NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01, Clinical Trial Optional) RFA-AI-22-059, Consortium for Design of TB Drug Regimens (UM1, Clinical Trial Not Allowed) NOT-AI-22-064, Notice of Special Interest (NOSI)—Halting Tuberculosis (TB) Transmission NOT-HD-22-043, Notice of Special Interest (NOSI)—Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE Initiative PAR-22-225, NIAID Investigator-Initiated Program Project Applications (P01, Clinical Trial Not Allowed) NOT-OD-22-208, Notice of Special Interest (NOSI)—Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp, Clinical Trial Optional) Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, September 21, 2022 — Add Comment